Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine

Author:

Marriott Anthony C.ORCID,Gooch Karen E.,Brown Phillip J.ORCID,Ryan Kathryn A.ORCID,Jones Nicola J.,Merredew Natasha,Wiblin Nathan,Dibben OliverORCID,Bright Helen,Hallis Bassam,Whittaker Catherine J.,Carroll Miles W.

Abstract

AbstractLive attenuated influenza vaccine (LAIV) is widely used to protect humans from seasonal influenza infection, particularly in children. In contrast to inactivated vaccines, the LAIV can induce both mucosal and cellular immune responses. Here we show that a single dose of monovalent H1N1pdm09-specific LAIV in the ferret model is fully protective against a subsequent wild-type H1N1pdm09 challenge, and furthermore reduces the severity of disease following challenge with a different influenza A subtype (H3N2). The reduced severity comprised reductions in weight loss and fever, as well as more rapid clearance of virus, compared to non-vaccinated H3N2-challenged ferrets. No H3N2-neutralizing antibodies were detected in vaccinated ferret sera. Rather, heterosubtypic protection correlated with interferon-gamma+ (IFN-γ+) T-cell responses measured in peripheral blood and in lung lymphocytes. The IFN-γ+ cells were cross-reactive to H3N2 virus even when obtained from vaccinated animals that had never been exposed to H3N2 virus. We believe this study provides compelling evidence that the LAIV can provide a significant reduction in infection and symptoms when challenged with heterosubtypic influenza strains not included in the LAIV, highlighting the importance of cross-reactive T-cells in the design of a universal influenza vaccine.

Funder

This work was funded by Public Health England.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Reference36 articles.

1. Petrova, V. N. & Russell, C. A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 16, 60 (2018).

2. Phillipson, J. E., Babecoff, R. & Ben-Yedida, T. Is a universal influenza vaccine feasible? Therapeutic Adv. Vcacines Immunother. 7, 1–6 (2019).

3. Quiñones-Parra, S., Loh, L., Brown, L. E., Kedzierska, K. & Valkenburg, S. A. Universal immunity to influenza must outwit immune evasion. Front. Microbiol. 5, 285 (2014).

4. Elbahesh, H., Saletti, G., Gerlach, T. & Rimmelzwaan, G. F. Broadly protective influenza vaccines: design and production platforms. Curr. Opin. Virol. 34, 1–9 (2019).

5. Rudenko, L. & Isakova-Sivak, I. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. Expert Rev. Vaccines 14, 395–412 (2015).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3